Financial News
Latest News about NVO
Recent news which mentions NVO
   Decoding Novo Nordisk's Options Activity: What's the Big Picture?
   
  November 11, 2024
  Tickers 
   NVO
  
  
  From Benzinga
 
   Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
   
  
  
  November 11, 2024
  From Benzinga
 
   Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?
   
  
  
  November 10, 2024
  From Motley Fool
 
   Is Viking Therapeutics a Buy on the Dip?
   
  
  
  November 10, 2024
  From Motley Fool
 
   Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
   
  
  
  November 08, 2024
  From Benzinga
 
   Investors Like Certainty. Trump's Win Gave Them Some.
   
  
  
  November 08, 2024
  From Motley Fool
 
   Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware
   
  
  
  November 07, 2024
  From Benzinga
 
   Forecasting The Future: 7 Analyst Projections For Novo Nordisk
   
  November 06, 2024
  Tickers 
   NVO
  
  
  From Benzinga
 From Benzinga
 
   Ozempic/Wegovy Maker Maintains Q3 Sales Growth On Booming Demand
   
  
  
  November 06, 2024
  From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  November 05, 2024
  From Benzinga
 
   $1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today
   
  
  
  November 05, 2024
  From Benzinga
 From Benzinga
 
   Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug
   
  
  
  November 04, 2024
  From Benzinga
 
   What's Going On With Hims & Hers Health Stock Monday?
   
  
  
  November 04, 2024
  From Benzinga
 
   As Race To Best 'Miracle' Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%
   
  
  
  November 04, 2024
  From Benzinga
 
   Could This Near Trillion-Dollar Stock Be a Millionaire Maker?
   
  
  
  November 03, 2024
  From Motley Fool
 From Benzinga
 
   Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
   
  
  
  October 31, 2024
  From Benzinga
 
   Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why
   
  
  
  October 30, 2024
  From Benzinga
 From Benzinga
 
   A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years
   
  
  
  October 30, 2024
  From Motley Fool
 
   1 Huge New Reason to Buy Eli Lilly or Novo Nordisk Stock Right Now and Hold It Forever
   
  
  
  October 29, 2024
  From Motley Fool
 
   Neuralink's Promise For Alzheimer's Has A Crucial Time Window — Elon Musk Explains Why
   
  
  
  October 29, 2024
  From Benzinga
 Tickers 
   NVO
  
  
  From Motley Fool
 
   Benzinga Bulls And Bears: Nvidia, Tesla, MicroStrategy, Plug Power — And Crypto Traders Anticipate Dogecoin Topping 50 Cents
   
  
  
  October 26, 2024
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

 
  
 
 
 










